Contact this trialFirst, we need to learn more about you.
Cell Therapy
Treg Cells + Everolimus for Kidney Transplant Rejection
Recruiting1 award4 criteria
Lexington, Kentucky
This trial is investigating the use of Treg cells to prevent kidney rejection in patients undergoing a solitary kidney transplant. 12 participants will be enrolled at the University of Kentucky.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.